{"name":"Universidad Miguel Hernandez de Elche","slug":"universidad-miguel-hernandez-de-elche","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Antimicrobial agent","genericName":"Antimicrobial agent","slug":"antimicrobial-agent","indication":"Bacterial infections","status":"phase_2"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Ibuprofen and paracetamol","genericName":"Ibuprofen and paracetamol","slug":"ibuprofen-and-paracetamol","indication":"Pain management","status":"phase_2"}]}],"pipeline":[{"name":"Antimicrobial agent","genericName":"Antimicrobial agent","slug":"antimicrobial-agent","phase":"phase_2","mechanism":"Antimicrobial agents work by inhibiting bacterial cell wall synthesis, protein synthesis, or interfering with essential bacterial processes.","indications":["Bacterial infections"],"catalyst":""},{"name":"Ibuprofen and paracetamol","genericName":"Ibuprofen and paracetamol","slug":"ibuprofen-and-paracetamol","phase":"phase_2","mechanism":"Ibuprofen is a non-selective COX inhibitor, while paracetamol is a weak inhibitor of COX enzymes and also acts on TRPV1 receptors.","indications":["Pain management","Fever reduction","Inflammation"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNSEVxUEdZYjZuZXhNNlpTSkpJWVM0WjFuWi1PSC1XSlE1TkdsaVZKQ2RkQUNVMWZNZEI2RGV4c3N2a1EzNWNsaTcwTW5MalNmZHdtSEdwTGxKa2xkM2ZoaFpRb1RnNDZCSzVXXzI5VFJDaHptamtRb2x1VzRQd2dWNTlWWTVaaFBod1ZBalBib2FmQnFnQ2syN2NjUXJSN0YxaGNVeWEzaExVeDQ?oc=5","date":"2024-12-04","type":"trial","source":"SciTechDaily","summary":"New Study Links “Safer” BPA Alternatives to Obesity, Diabetes, and Hormone Disruption - SciTechDaily","headline":"New Study Links “Safer” BPA Alternatives to Obesity, Diabetes, and Hormone Disruption","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE9zWlo4QmU5aG9vaHlfRC1GSXh0U2E4QjBvRmxLSWR4bTh0ejJreXVRY1NnaV8xUFBaclJDV1ZHRkNaU24zMFhMUk5iODVBZkNYdVc5YzFyeHFKRFZZYllyVTMxU2J6bnJiYm11eW0yM2FYVll3OHJQRnA5OGc?oc=5","date":"2023-06-20","type":"pipeline","source":"Universidad Nacional de Rosario","summary":"Doctor Honoris Causa for Jorge Manzanares Robles - Universidad Nacional de Rosario","headline":"Doctor Honoris Causa for Jorge Manzanares Robles","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}